AXIM Biotechnologies Appoints New Chief Executive Officer

Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced that it has appointed Christine Silverstein to the position of Chief Financial Officer and named Edward Carr as Chief Accounting Officer.

"Christine is a thoughtful and strategic leader who is truly passionate about our Company's commitment to serve patients and shareholders alike. Her healthcare and in-depth capital markets experience has been instrumental in the implementation of Abeona's financial and operational strategy and will play a vital role in our ability to generate higher growth and enhance shareholder value," commented João Siffert, M.D., Interim Chief Executive Officer of Abeona. "Ed has considerable financial and accounting experience and, in the short period since joining Abeona, has implemented important financial practices that yielded efficiencies and further strengthened our operations. Together, Christine and Ed's appointments round out our internal capabilities that are imperative to our success."

Ms. Silverstein was previously Senior Vice President, Finance and Investor Relations for Abeona.  Prior to joining Abeona in 2016, she served as Head of Investor Relations at Relmada Therapeutics, Inc. a clinical stage specialty pharmaceutical company. This was preceded by her role as Managing Director at SCO Financial Group, where she drove strategy on capital formation and business development opportunities for portfolio companies.  Ms. Silverstein began her career as an investment advisor at Royal Alliance Associates, Inc. before leading teams at corporate advisory firms, The Investor Relations Group and Corporate Profile, LLC.  She is a member of the National Investor Relations Institute and holds a B.S. from the Peter Tobin College of Business, St. John's University.

Prior to Abeona, Mr. Carr most recently served as Vice President and Assistant Controller at Coty Inc., a publicly listed multinational company.  Prior to Coty, he served for more than 10 years as Chief Accounting Officer at Foster Wheeler AG, which was preceded by his tenure at Ernst & Young LLP.  He is a Certified Public Accountant and holds a B.S. and Master of Professional Accountancy from West Virginia University.